Chest wall/parietal pleural invasions worsen prognosis in T4 non-small cell lung cancer patients after resection.
Aged
Carcinoma, Non-Small-Cell Lung
/ pathology
Female
Follow-Up Studies
Hospitals, University
Humans
Lung Neoplasms
/ pathology
Male
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Pleura
/ pathology
Postoperative Period
Prognosis
Retrospective Studies
Smoking
Survival Rate
Thoracic Wall
/ pathology
5-Year survival rate
Prognostic factor
Surgical resection
T4 lung cancer
Journal
General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
01
2019
accepted:
18
02
2019
pubmed:
23
2
2019
medline:
9
1
2020
entrez:
22
2
2019
Statut:
ppublish
Résumé
Appropriate selection for surgery is particularly important in T4 non-small cell lung cancer patients. In clinical settings, patients those who are positive for T4 criteria occasionally are also positive for T3 factors which are independently defined from original T4 or even have multiple T4 factors. Significance of these factors on prognosis is still unknown. We retrospectively reviewed clinicopathorogical data of 113 patients with T4 non-small cell lung cancer those who underwent surgery between 1990 and 2015 in Tohoku University Hospital. Significance on prognosis of single or multiple T4 factors and with or without independent T3 factors were statistically analyzed. No significant difference was seen in the 5-year survival rate between patients with single (35.6%) and multiple (31.4%) T4 factors (P = 0.94), but the rate was significantly lower when patients also had independent T3 factors (19.6%) compared with when they did not (42.5%) (P = 0.011). The 5-year survival rate was particularly lower among patients with invasion of the chest wall or parietal pleura (8.1%) than in those without (40.6%) (P = 0.0052). Invasion of the chest wall or parietal pleura is poor prognostic factors in T4 non-small cell lung cancer patients.
Identifiants
pubmed: 30790239
doi: 10.1007/s11748-019-01093-8
pii: 10.1007/s11748-019-01093-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
788-793Références
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5
pubmed: 18805134
Interact Cardiovasc Thorac Surg. 2010 Oct;11(4):473-9
pubmed: 20621998
Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5038s-5044s
pubmed: 16000611
J Bronchology Interv Pulmonol. 2019 Jul;26(3):155-165
pubmed: 30119069
J Thorac Cardiovasc Surg. 2005 Apr;129(4):804-8
pubmed: 15821646
Chest. 2005 Nov;128(5):3519-25
pubmed: 16304308
Ann Thorac Surg. 2009 Aug;88(2):372-8
pubmed: 19632375
Ann Thorac Surg. 2010 Dec;90(6):1773-7
pubmed: 21095307
Ann Thorac Surg. 2012 May;93(5):1633-40
pubmed: 22480394
Gen Thorac Cardiovasc Surg. 2017 Jun;65(6):321-328
pubmed: 28349384
Ann Thorac Surg. 2003 Jun;75(6):1745-51; discussion 1751
pubmed: 12822610
J Thorac Oncol. 2013 Jun;8(6):759-65
pubmed: 23608818
Interact Cardiovasc Thorac Surg. 2012 Apr;14(4):415-9
pubmed: 22269143
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Ann Thorac Surg. 2001 Sep;72(3):885-8
pubmed: 11565675
Lung Cancer. 2007 May;56(2):223-7
pubmed: 17229487
World J Surg. 2009 Mar;33(3):492-6
pubmed: 19132442
J Thorac Cardiovasc Surg. 2001 Oct;122(4):796-802
pubmed: 11581616
Surg Clin North Am. 2002 Jun;82(3):573-87
pubmed: 12371586
Eur J Cardiothorac Surg. 2003 Dec;24(6):1013-8
pubmed: 14643822
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738